CervoMed Inc. Proceeds from (Repayments of) Bank Overdrafts
CervoMed Inc. (CRVO) reported Proceeds from (Repayments of) Bank Overdrafts of -$62.80 thousand for the 12-month period ending 2011-12-31, per its 10-K/A filed 2013-04-24.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfBankOverdrafts · last filed 2013-04-24
- CervoMed Inc. proceeds from (repayments of) bank overdrafts for the quarter ending 2011-12-31 was -$6.00, a 100.01% decline year-over-year.
- CervoMed Inc. proceeds from (repayments of) bank overdrafts for the quarter ending 2010-12-31 was $62.80K.
- CervoMed Inc. proceeds from (repayments of) bank overdrafts for the quarter ending 2010-09-30 was $0.00.
- CervoMed Inc. proceeds from (repayments of) bank overdrafts for fiscal 2011 was -$62.80K, a 215.15% decline from fiscal 2010.
- CervoMed Inc. proceeds from (repayments of) bank overdrafts for fiscal 2010 was $54.54K.
| Period end | Proceeds from (Repayments of) Bank Overdrafts 3 month | Proceeds from (Repayments of) Bank Overdrafts 6 month | Proceeds from (Repayments of) Bank Overdrafts 9 month | Proceeds from (Repayments of) Bank Overdrafts 9 month as first filed | Proceeds from (Repayments of) Bank Overdrafts 12 month |
|---|---|---|---|---|---|
| 2011-12-31 | -$6.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-04-24 | -$62.80K 10-K/A · filed 2013-04-24 | |||
| 2011-09-30 | -$62.79K 10-Q · filed 2012-11-19 | -$62.80K 10-Q · filed 2011-11-21 | |||
| 2010-12-31 | $62.80K derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-21 | $62.80K derived: sum of 2 quarters · filed 2012-05-21 | $54.54K 10-K · filed 2012-05-21 | ||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-21 | -$8.26K 10-Q · filed 2011-11-21 | |||
| 2010-06-30 | -$8.26K 10-Q · filed 2011-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |